Related Experiment Video
Updated: Jan 3, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Improving growth of infants with congenital heart disease using a consensus-based nutritional pathway
Luise V Marino1, Mark J Johnson2, Natalie J Davies3
1Department of Dietetics/ SLT, University Hospital Southampton NHS Foundation Trust, SO16 6YD, UK; NIHR Biomedical Research Centre Southampton, University Hospital Southampton NHS Foundation Trust, Southampton, S016 6YD, UK; School of Health Sciences, University of Southampton, UK.
Insights
A pre-operative nutritional pathway improved growth in infants with congenital heart disease (CHD). This intervention also significantly reduced paediatric-intensive care unit length of stay (PICU-LOS), suggesting better clinical outcomes.
Area of Science:
- Pediatric Cardiology
- Nutritional Science
- Critical Care Medicine
Background:
- Infants with congenital heart disease (CHD) frequently experience growth failure before surgery.
- Pre-operative growth failure in CHD is linked to longer paediatric-intensive care unit stays (PICU-LOS) and increased post-operative complications.
- Optimizing nutritional status pre-operatively is crucial for improving outcomes in these vulnerable infants.
Purpose of the Study:
- To evaluate the impact of a consensus-based, pre-operative nutritional pathway on growth in infants with CHD.
- To assess the effect of this nutritional intervention on clinical outcomes, including PICU-LOS.
- To determine if multidisciplinary team support within the nutritional pathway enhances patient management.
Main Methods:
- A single-centre prospective pilot study compared an intervention group (n=44) with a historic control group (n=38).
- The intervention involved a pre-operative nutritional pathway with weekly dietitian contact for high-risk infants, focusing on weight gain and feeding support.
- Growth (weight-for-age z-score [WAZ] and height-for-age z-score [HAZ]) and PICU-LOS were measured at 4 and 12 months of age.
Main Results:
- The intervention group showed improved weight-for-age z-score (WAZ) at 12 months compared to controls (p=0.03).
- Height-for-age z-score (HAZ) was significantly better in the intervention group at 12 months (p=0.04).
- Paediatric-intensive care unit length of stay (PICU-LOS) was significantly reduced in the intervention group (8.2 days vs. 18.3 days, p=0.006).
Conclusions:
- A pre-operative nutritional pathway effectively maintained overall weight and improved growth in infants with CHD.
- The intervention led to a significant reduction in PICU-LOS, potentially due to improved nutritional status.
- This pathway, supported by a multidisciplinary team, demonstrates promise for enhancing clinical outcomes in pediatric cardiac surgery patients.
Objective:
Infants with congenital heart disease (CHD) often experience growth failure prior to surgery, which is associated with increased paediatric-intensive-care unit length of stay (PICU-LOS) and post-operative complications. This study assessed the impact of a pre-operative, consensus-based nutritional pathway (including support from a multi-disciplinary team) on growth and clinical outcome.
Design:
Single-centre prospective pilot study.
Setting:
Tertiary paediatric cardiology surgical centre.
Patients:
Infants with CHD.
Intervention:
Infants with CHD were followed for up to 4-months-of-age before cardiac surgery and then to 12-months-of-age following the implementation of the consensus-based nutritional-pathway (Intervention group: November 2017-August 2018), with outcomes compared to a historic control group. The nutrition pathway involved a dietitian contacting parents of infants with the highest risk of growth failure weekly; reviewing weight gain and providing feeding support.
Main Outcome Measure:
Growth (weight-for-age, WAZ, and height-for-age-z-score, HAZ) at 4 and 12 months-of-age.
Results:
44 infants in the intervention group were compared to 38 in the control group. Median (inter quartile range) change in WAZ from birth to 4 months-of-age (-0.9 (-1.5, 0.7)) and from birth to 12 months-of-age (-0.09 (-1.3, 1.1)) in the intervention group compared to the control group (-1.5 (-2.0, -0.4) (p = 0.04)) at 4 months-of age and at 12 months-of-age (-0.4 (1.9, 0.2) (p = 0.03)). HAZ at 4 months-of-age was -0.7 (-1.4, -0.1) vs. -1.0 (-1.9, -0.3) (p = 0.6) in the intervention and control groups respectively, and at 12 months-of-age HAZ was -0.7 (-1.9, -0.07) in the intervention group vs.-1.6 (-2.6, -0.4) in the control group (p = 0.04). Duration of PICU-LOS was 8.2 ± 11.6 days intervention vs. 18.3 ± 24.0 days control (p = 0.006).
Conclusion:
Overall weight was well maintained and growth improved in infants who followed the pre-operative nutritional-pathway. The duration of PICU-LOS was significantly lower in the intervention group, which may be due to improved nutritional status, although this requires further investigation.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Enteral Nutrition I: Orogastric and Nasogastric Feeding
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...

